Table 7.
Outcomes by conditioning regimen subtype
Outcome event | Non-myeloablative/RIC | Myeloablative | P-value | ||
---|---|---|---|---|---|
N eval. | Prob (95% CI)a | N eval. | Prob (95% CI) | ||
Transplant-related mortality | 33 | 73 | |||
@ 100days | 9 (2-22) | 23 (14-33) | 0.0437 | ||
@ 1 year | 15 (6-30) | 30 (20-41) | 0.0742 | ||
@ 3 years | 19 (8-34) | 30 (20-41) | 0.1803 | ||
@ 5 years | 19 (8-34) | 30 (20-41) | 0.1803 | ||
Relapse | |||||
@ 1 year | 65 (46-79) | 27 (17-37) | 0.0001 | ||
@ 3 years | 69 (49-82) | 43 (31-54) | 0.011 | ||
@ 5 years | 69 (49-82) | 47 (35-58) | 0.036 | ||
Disease-free survival | 33 | 73 | P_overall=0.167 | ||
@ 1 year | 19 (8-34) | 43 (31-54) | 0.0097 | ||
@ 3 years | 13 (4-27) | 27 (17-38) | 0.0776 | ||
@ 5 years | 13 (4-27) | 22 (13-33) | 0.2175 | ||
Overall survival | 35 | 96 | P_overall=0.128 | ||
@ 1 year | 51 (33-67) | 56 (45-65) | 0.6248 | ||
@ 3 years | 16 (6-30) | 34 (25-44) | 0.026 | ||
@ 5 years | 16 (6-30) | 25 (17-35) | 0.2348 |
Abreviations: CI: confidence interval, RIC: reduced intensity conditioning